CSNpharm
Betaine can enhance the specificity of the polymerase chain reaction by eliminating the base pair composition dependence of DNA melting, which is a natural product isolated and purified from the roots of Beta vulgaris.
More Information
Supplier Page
CSNpharm
Betaine can enhance the specificity of the polymerase chain reaction by eliminating the base pair composition dependence of DNA melting, which is a natural product isolated and purified from the roots of Beta vulgaris.
More Information
Supplier Page
CSNpharm
Betaine HCl is an acidic form of betaine and a vitamin-like substance found in grains and other foods. It improves the amplification of DNA by reducing the formation of secondary structure in GC-rich regions.
More Information
Supplier Page
CSNpharm
CSNpharm
Betamipron is an adjunct agent used in combination with panipenem to inhibit panipenem uptake into the renal tubule and prevent nephrotoxicity.
More Information
Supplier Page
CSNpharm
Betamipron is an adjunct agent used in combination with panipenem to inhibit panipenem uptake into the renal tubule and prevent nephrotoxicity.
More Information
Supplier Page
CSNpharm
Bethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors without any effect on nicotinic receptors.
More Information
Supplier Page
CSNpharm
Bethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors without any effect on nicotinic receptors.
More Information
Supplier Page
CSNpharm
CSNpharm
BETP
50mg
| ≥97%
CSNpharm
BETP is an agonist of glucagon-like peptide-1 (GLP-1) receptor, with EC50s of 0.66 and 0.755 μM for human and rat GLP-1 receptor, respectively.
More Information
Supplier Page
BETP
25mg
| ≥97%
CSNpharm
BETP is an agonist of glucagon-like peptide-1 (GLP-1) receptor, with EC50s of 0.66 and 0.755 μM for human and rat GLP-1 receptor, respectively.
More Information
Supplier Page
BETP
5mg
| ≥97%
CSNpharm
BETP is an agonist of glucagon-like peptide-1 (GLP-1) receptor, with EC50s of 0.66 and 0.755 μM for human and rat GLP-1 receptor, respectively.
More Information
Supplier Page
BETP
100mg
| ≥97%
CSNpharm
BETP is an agonist of glucagon-like peptide-1 (GLP-1) receptor, with EC50s of 0.66 and 0.755 μM for human and rat GLP-1 receptor, respectively.
More Information
Supplier Page
BETP
10mg
| ≥97%
CSNpharm
BETP is an agonist of glucagon-like peptide-1 (GLP-1) receptor, with EC50s of 0.66 and 0.755 μM for human and rat GLP-1 receptor, respectively.
More Information
Supplier Page
CSNpharm
Betrixaban is a highly potent, selective, and orally efficacious factor Xa inhibitor with IC50 of 1.2 nM (inhibition of Factor 10a).
More Information
Supplier Page
CSNpharm
Betrixaban is a highly potent, selective, and orally efficacious factor Xa inhibitor with IC50 of 1.2 nM (inhibition of Factor 10a).
More Information
Supplier Page
CSNpharm
Betrixaban is a highly potent, selective, and orally efficacious factor Xa inhibitor with IC50 of 1.2 nM (inhibition of Factor 10a).
More Information
Supplier Page
CSNpharm
Betrixaban is a highly potent, selective, and orally efficacious factor Xa inhibitor with IC50 of 1.2 nM (inhibition of Factor 10a).
More Information
Supplier Page
CSNpharm
Betrixaban is a highly potent, selective, and orally efficacious factor Xa inhibitor with IC50 of 1.2 nM (inhibition of Factor 10a).
More Information
Supplier Page
CSNpharm
Betrixaban is a highly potent, selective, and orally efficacious factor Xa inhibitor with IC50 of 1.2 nM (inhibition of Factor 10a).
More Information
Supplier Page
CSNpharm
Betulinic acid, a pentacyclic triterpene isolated and purified from the herbs of Ziziphus jujuba, selectively induces apoptosis in tumor cells, also is an inhibitor of HIV-1 with EC50 of 1.4 μ M.
More Information
Supplier Page
CSNpharm
Betulinic acid, a pentacyclic triterpene isolated and purified from the herbs of Ziziphus jujuba, selectively induces apoptosis in tumor cells, also is an inhibitor of HIV-1 with EC50 of 1.4 μ M.
More Information
Supplier Page
CSNpharm
Betulinic acid, a pentacyclic triterpene isolated and purified from the herbs of Ziziphus jujuba, selectively induces apoptosis in tumor cells, also is an inhibitor of HIV-1 with EC50 of 1.4 μ M.
More Information
Supplier Page
CSNpharm
Betulinic acid, a pentacyclic triterpene isolated and purified from the herbs of Ziziphus jujuba, selectively induces apoptosis in tumor cells, also is an inhibitor of HIV-1 with EC50 of 1.4 μ M.
More Information
Supplier Page
CSNpharm
Betulonic acid, a natural product isolated and purified from the branch of Eucalyptus globulus Labill., belongs to the pentacyclic triterpenic derivative class, has antitumor activities.
More Information
Supplier Page
CSNpharm
Betulonic acid, a natural product isolated and purified from the branch of Eucalyptus globulus Labill., belongs to the pentacyclic triterpenic derivative class, has antitumor activities.
More Information
Supplier Page
CSNpharm
Bevantolol is a drug candidate for angina and hypertension that acted as both a beta blocker and a calcium channel blocker.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Bexarotene is a selective agonist of RXRβ (IC50 = 24 nM), RXRγ (IC50 = 25 nM) and RXRα (IC50 = 33 nM) with antineoplastic activity.
More Information
Supplier Page
CSNpharm
Bexarotene is a selective agonist of RXRβ (IC50 = 24 nM), RXRγ (IC50 = 25 nM) and RXRα (IC50 = 33 nM) with antineoplastic activity.
More Information
Supplier Page
CSNpharm
Bexarotene is a selective agonist of RXRβ (IC50 = 24 nM), RXRγ (IC50 = 25 nM) and RXRα (IC50 = 33 nM) with antineoplastic activity.
More Information
Supplier Page
CSNpharm
Bezafibrate is the agonist of PPAR and the EC50 for PPAR⍺, PPARβ, PPARγ is 50 , 20, and 60 nM respectively. It has hypolipidemic effect.
More Information
Supplier Page
CSNpharm
Bezafibrate is the agonist of PPAR and the EC50 for PPAR⍺, PPARβ, PPARγ is 50 , 20, and 60 nM respectively. It has hypolipidemic effect.
More Information
Supplier Page
CSNpharm
BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.
More Information
Supplier Page
CSNpharm
BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.
More Information
Supplier Page
CSNpharm
BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.
More Information
Supplier Page
CSNpharm
BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.
More Information
Supplier Page
CSNpharm
BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.
More Information
Supplier Page
BHPI
5mg
| ≥98%
CSNpharm
BHPI is a potent inhibitor of nuclear estrogen–ERα-regulated gene expression and elicits sustained ERα-dependent activation of the endoplasmic reticulum (EnR) stress sensor, the unfolded protein response (UPR), and persistent inhibition of protein synthesis.
More Information
Supplier Page
BHPI
1mg
| ≥98%
CSNpharm
BHPI is a potent inhibitor of nuclear estrogen–ERα-regulated gene expression and elicits sustained ERα-dependent activation of the endoplasmic reticulum (EnR) stress sensor, the unfolded protein response (UPR), and persistent inhibition of protein synthesis.
More Information
Supplier Page
BHPI
50mg
| ≥98%
CSNpharm
BHPI is a potent inhibitor of nuclear estrogen–ERα-regulated gene expression and elicits sustained ERα-dependent activation of the endoplasmic reticulum (EnR) stress sensor, the unfolded protein response (UPR), and persistent inhibition of protein synthesis.
More Information
Supplier Page
BHPI
25mg
| ≥98%
CSNpharm
BHPI is a potent inhibitor of nuclear estrogen–ERα-regulated gene expression and elicits sustained ERα-dependent activation of the endoplasmic reticulum (EnR) stress sensor, the unfolded protein response (UPR), and persistent inhibition of protein synthesis.
More Information
Supplier Page
BHPI
10mg
| ≥98%
CSNpharm
BHPI is a potent inhibitor of nuclear estrogen–ERα-regulated gene expression and elicits sustained ERα-dependent activation of the endoplasmic reticulum (EnR) stress sensor, the unfolded protein response (UPR), and persistent inhibition of protein synthesis.
More Information
Supplier Page
BHQ
100mg
| ≥98%
CSNpharm
BHQ
250mg
| ≥98%
CSNpharm
CSNpharm
BI-2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM, BI2536 shows 4- and 11-fold greater selectivity against Plk2 and Plk3 and also is a BRD4 inhibitor (IC50= 25 nM).
More Information
Supplier Page
CSNpharm
BI-2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM, BI2536 shows 4- and 11-fold greater selectivity against Plk2 and Plk3 and also is a BRD4 inhibitor (IC50= 25 nM).
More Information
Supplier Page
CSNpharm
BI-2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM, BI2536 shows 4- and 11-fold greater selectivity against Plk2 and Plk3 and also is a BRD4 inhibitor (IC50= 25 nM).
More Information
Supplier Page
